Profiel
Gregory T.
Bates worked as Senior VP-Regulatory Affairs & Quality at XenoPort, Inc. He then worked as Vice President-Regulatory Affairs at ATAI Life Sciences NV from 2019 to 2022.
Bates received his undergraduate degree from the University of California, Berkeley and his doctorate degree from the University of California, Davis.
Eerdere bekende functies van Gregory T. Bates
| Bedrijven | Functie | Einde |
|---|---|---|
| ATAI LIFE SCIENCES N.V. | Algemeen Adviseur | 01-05-2022 |
| XENOPORT, INC. | Algemeen Adviseur | - |
Opleiding van Gregory T. Bates
| University of California, Berkeley | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ATAI LIFE SCIENCES N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
